Company News in the Life Science Industry

ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ -- Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline... Read more ››

DUBLIN and BRIDGEWATER, N.J., Dec. 13, 2019 /PRNewswire/ -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication and label expansion for VASCEPA(®) (icosapent ethyl) capsules. After more than a decade of development... Read more ››

NEW YORK, Dec. 13, 2019 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

NEW YORK, Dec. 13, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) today celebrated the decision by the US Food and Drug Administration (FDA) to grant accelerated marketing approval to golodirsen (Vyondys 53) for the treatment of Duchenne muscular dystrophy (DMD) in patients amenable... Read more ››

LEXINGTON, Mass., Dec. 13, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. (TSE: 4502) (NYSE:TAK) ("Takeda") and MiTest Health LLC ("MiTest"), a pioneering health technology company, today announced an exclusive partnership to optimize MiTest's personalized risk and outcome prediction tool... Read more ››

SOUTH PLAINFIELD, N.J., Dec. 13, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 9, 2019 it approved non-statutory stock options to purchase an aggregate of 59,150 shares of its common stock to 17 new employees. The awards were made pursuant to the... Read more ››

SILVER SPRING, Md., Dec. 13, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood)... Read more ››

EXTON, Pa., Dec. 13, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in... Read more ››

BUFFALO, N.Y., Dec. 13, 2019 /PRNewswire/ -- Garwood Medical Devices announced today that its Series B round closed 11/30/2019 at $3.7 million, over-subscribed by $700,000. The WNY Impact Investment Fund, who invested $500,000, 17 investors from Series A, and 18 other new investors all joined... Read more ››

SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing... Read more ››